Senior insider sale
EVP, General Counsel, Corp Sec at VIR BIOTECHNOLOGY, INC. — senior position signals high conviction
$116.3K
12.59K shares
What this filing means
DE VERNEUIL VANINA plans to sell 12.59K shares of VIR BIOTECHNOLOGY, INC. valued at approximately $116.3K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 2/26/2025ACC: 0001950047-25-001287
Officer· EVP, General Counsel, Corp Sec
Since Feb 2026
12.59K
Shares to sell
$116.3K
Approx. market value
7.37K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
Restricted Stock Units
N/A
2/22/2025
7.37KTotal acquired7.37K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/22/2025 | Restricted Stock Units N/A | 7.37K | — |
| Total | 7.37K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
5.14K
Market value
$48.6K
2/24/2025
—Completed
Units to sell
76.00
Market value
$624.73
12/2/2024
Planned — Approximate Date
NASDAQPlanned
Units to sell
7.37K
Market value
$67.1K
2/26/2025
Total
Units
12.59K
Value
$116.3K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
2/24/2025 | 5.14K | $48.6K | — | Completed |
12/2/2024 | 76.00 | $624.73 | — | Completed |
| Planned — Approximate Date | ||||
2/26/2025 | 7.37K | $67.1K | NASDAQ | Planned |
| Total | 12.59K | $116.3K | ||